Thus, although SLC7A11 could be a potential therapeutic target in ovarian cancer treatment, more studies are required to evaluate the role of SLC7A11 expression as a biomarker in ovarian cancer management. The gene discussed is SLC7A11; the disease is ovarian carcinoma.